Pilot study of volume contracted state and hospital outcome after stroke
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 14, 2017
- Accepted August 22, 2017
- First Published January 22, 2018.
Article Versions
- Previous version (January 22, 2018 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Mona N. Bahouth, MD,
- Andrew Gaddis, MHS,
- Argye E. Hillis, MD and
- Rebecca F. Gottesman, MD, PhD
- Mona N. Bahouth, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Johns Hopkins School of Medicine, Richard Starr Ross Clinician a Scientist Award
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Andrew Gaddis, MHS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Argye E. Hillis, MD and
Paid member of Data Safety Monitoring Board for Axovant
NONE
NONE
Stroke, Associate Editor, 2014-present; Aphasiology, Associate Editor, 2008-present, Practice Update Neurology, Associate Editor, 2015-present
NONE
Handbook of Adult Language Disorders, Taylor & Francis, 2015
NONE
The Charles Dana Foundation
NONE
NONE
NONE
NONE
(1) NIDCD RO1 DC05375 2008-current, PI (2) P50 DC014664, PI of project 2 and PI of clinical core, 2016-current (3)NIDCD, R01DC015466, PI, 2017-2023 (4)NINDS, R25, PI, 2009-present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Rebecca F. Gottesman, MD, PhD
Member of DSMB for "Sail-on" study, (PI: V. Urrutia), funded via Genentech (no compensation received).
NONE
Cardiothoracic Surgery Symposium; funds for travel (reimbursement)
Neurology, Associate Editor, 2015-present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Florbetapir isotope (18F-AV-45) provided for investigator-initiated research by Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly.
National Institutes of Health/ National Institute on Aging. 1R01AG040282, Principal Investigator, 9/2011-8/2021
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Correspondence
Dr. Bahouth mbahout1{at}jhmi.edu
Article usage
Cited By...
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.